Rachael Terry

6PUBLICATIONS
55CO-AUTHORS
Molecular targetsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Apr 27, 2026
Comprehensive Multiplatform Tyrosine Kinase Profiling Reveals Novel Actionable FGFR Aberrations across Sarcomas Affecting the Young.

|Mar 18, 2026
Comprehensive multi-platform tyrosine kinase profiling reveals novel actionable FGFR aberrations across sarcomas affecting the young.

Ashleigh M Fordham, Lauren M Brown, Chelsea Mayoh

|Dec 24, 2021
Enhancing the Potential of Immunotherapy in Paediatric Sarcomas: Breaking the Immunosuppressive Barrier with Receptor Tyrosine Kinase Inhibitors.

Emmy D G Fleuren, Rachael L Terry, Deborah Meyran

|Sep 28, 2021
Chimeric Antigen Receptor T cell Therapy and the Immunosuppressive Tumor Microenvironment in Pediatric Sarcoma.

Rachael L Terry, Deborah Meyran, Emmy D G Fleuren

|May 17, 2021
Dual Targeting of Chromatin Stability By The Curaxin CBL0137 and Histone Deacetylase Inhibitor Panobinostat Shows Significant Preclinical Efficacy in Neuroblastoma.

Lin Xiao, Klaartje Somers, Jayne Murray

|Apr 27, 2019
A niche-dependent myeloid transcriptome signature defines dormant myeloma cells.

Weng Hua Khoo, Guy Ledergor, Assaf Weiner

Pageof 1

Frequent Collaborators

4 joint publications

Chelsea Mayoh

3 joint publications

Paul G Ekert

3 joint publications

Andrew J Gifford

3 joint publications

Michelle Haber